Company Filing History:
8 out of 10 
1 out of 14 
1 out of 75 
Years Active: 1998-2021
Title: Inventor Thomas Grunwald: Pioneering Innovations in Pharmacology
Introduction: Thomas Grunwald, a renowned inventor based in Hamburg, Germany, has made significant contributions to the field of pharmacology with his innovative inventions. With a total of nine patents to his name, Grunwald's work is centered around enhancing immunotherapies and understanding the immune system's responses.
Latest Patents: Grunwald's latest patents showcase his expertise in creating pharmaceutical compositions that modulate immune responses. One of his notable inventions is the "Induction of antigen-specific tolerance by peripheral phagocytosis." This invention focuses on immunotherapy that combines antigen-specific approaches with peripheral tolerance-inducing mechanisms, utilizing liposomes and immune modulators to enhance T cell and B cell responses. Another significant patent is the "Controlled activation of complement components for use as an endogenous adjuvant." This invention aims to improve vaccine efficacy by using recombinant human C3-derivatives in combination with antigens for vaccination purposes.
Career Highlights: Throughout his career, Thomas Grunwald has had the privilege of working with prestigious institutions and companies, including Pls-design GmbH and the Klinikum Rechts Der Isar der Technischen Universität München. His innovative thinking and dedication to advancing pharmaceutical technologies have established him as a key figure in his field.
Collaborations: Grunwald has collaborated with several notable professionals, including Reinhard Bredehorst and Ingke Braren. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking pharmaceutical solutions.
Conclusion: Thomas Grunwald stands out as an influential inventor in the realm of pharmacology, with a focus on harnessing immune responses for therapeutic advancements. His innovative patents reflect a commitment to improving healthcare through scientific inquiry and collaboration. As he continues to explore the potential of immunotherapies, Thomas Grunwald's contributions will undoubtedly have a lasting impact on the field.